Investment Co PJSC Mubadala
RXRXInvestment Co PJSC Mubadala serves as 10% Owner at Recursion Pharmaceuticals, Inc. (RXRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Investment Co PJSC Mubadala's Insider Trading at Recursion Pharmaceuticals, Inc. (RXRX)
Buys
18 · $62.90M
Sells
0 · $0.00
Total Shares Bought
4,471,767
Total Shares Sold
0
Related Insiders
Christopher Gibson
Director
RXRXSell · Jun 5, 2026
Najat Khan
director, officer: CEO and President
RXRXSell · Jun 5, 2026
Blake Borgeson
Director
RXRXSell · Jun 4, 2026
Namandje Bumpus
director
RXRXSell · Jun 4, 2026
Ben R Taylor
officer: Chief Financial Officer
RXRXSell · Mar 18, 2026
David Hallett
Chief Scientific Officer
RXRXSell · Feb 17, 2026